Kathleen Sereda Glaub

Kathleen Sereda Glaub has extensive experience in the field of finance and board directorship. Kathleen Sereda began their career in 1980 as a Treasury Manager and Financial Analyst at Intel Corporation. Kathleen Sereda then moved to Genentech Inc. in 1985 as Treasurer. In 1993, they became SVP and CFO at Cell Genesys. In 2001, they became President at Plexxikon Inc. and in 2013, they became CEO and Board Director at Afferent Pharmaceuticals. Kathleen Sereda also serves as Board Director, Advisor, and Investor at KSG & Associates since 2013. In 2014, they became Board Director at Codexis, Inc. and in 2018, they became Board Director at Escient Pharmaceuticals and IO Biotech, as well as Executive Chair to Board of Directors at CuraSen Therapeutics, Inc.

Kathleen Sereda Glaub holds a Master of Business Administration (MBA) from Northwestern University - Kellogg School of Management, with a focus in Finance & Marketing. Kathleen Sereda also holds a Bachelor of Arts (BA) from the University of California, Berkeley.